Milestones

1. The research line on first psychotic episodes, active since the beginning of the group, is maintained with the projects AGES-CM 3 (S2022/BMD-7216) of the I+D Grants program in Biomedicine of the CAM, and the ISCIII projects SchizOMICS (ICI21/00089) of the call for Projects of Independent Clinical Research and FARMAPRED-PEP (PMP21/00085) of the call for Projects of Personalized Medicine.
2. The line of research on impulsive-compulsive disorders and gambling disorder continues through the third consecutive project of the AES call of the ISCIII (PI22/01183) and the SUBV23/00023 project of the Ministry of Consumer Affairs, which finances the hiring of a research psychologist.
3. Ortega MA, Fraile O, García C, Díaz R, López L, Monserrat J, Barrena S, Álvarez MA, Lahera G, Álvarez M. Understanding immune system dysfunction and its context in mood disorders: psychoneuroimmunoendocrinology and clinical interventions. Mil Med Res. 2024;11(1): 80 - 80. DOI:10.1186/s40779-024-00577-w.
4. Article on bipolar disorder: Serra M, Clougher D, Solé B, Sánchez J, González A, Jiménez E, Amann BL, Balanzá V, Tabarés R, Arango C, Accardo V, García MP, Ibáñez Á, Crespo JM, Ayuso JL, Amoretti S, Torrent C, Martínez A, Vieta E, CIBERSAM Functional Remediation G. The impact of sex in the effectiveness of functional remediation in bipolar disorder. Acta Psychiatr Scand. 2024;150(6): 543 - 561. DOI:10.1111/acps.13748.
5. Publication on first psychotic episodes: Llorca V, Madero S, Amoretti S, Cuesta MJ, Moreno C, González A, Bergé D, Rodriguez R, Roldán A, García MÁ, Ibáñez A, Usall J, Contreras F, Mezquida G, García C, Berrocoso E, Bernardo M, Bioque M, 2EPs G. Inflammatory blood cells and ratios at remission for psychosis relapse prediction: Athree-year follow-up of a cohort of first episodes of schizophrenia. Schizophr Res. 2024;267: 24 - 31. DOI:10.1016/j.schres.2024.03.011.